Yu Ming Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yu Ming Fu has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Alexander K. C. Leung
Cumming School of Medicine, University of Calgary
1 shared publication Chi Chiu Shek
Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong Special Administrative Region, China
1 shared publicationChi Hang Wong
Department of Paediatric and Adolescent Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong Special Administrative Region, China
1 shared publication- Chi-Man Victor Chan
Department of Paediatric and Adolescent Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong Special Administrative Region, China
1 shared publication - Chung Mo Chow
Virtus Medical Group, Hong Kong
1 shared publication - Fernando Scaglia
Department of Molecular and Human Genetics Baylor College of Medicine Houston Texas USA
1 shared publication
Latest Publications
- Open Access
- 1 October 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 111, 288-294
Epidemiology and Trends of Infective Meningitis in Neonates and Infants Less than 3 Months Old in Hong Kong
- 1 October 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 111, 288-294
Open AccessEpidemiology and Trends of Infective Meningitis in Neonates and Infants Less than 3 Months Old in Hong Kong
- Open Access
- 17 April 2020
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2020, 1-5
Severe Generalized Epidermolysis Bullosa Simplex in Two Hong Kong Children due to De Novo Variants in KRT14 and KRT5
We report two Hong Kong children with severe generalized epidermolysis bullosa simplex (EBS), the most severe form of EBS, without a family history of EBS. EBS is a rare genodermatosis usually inherited in an autosomal dominant fashion although rare autosomal recessive cases have been reported. Genetic studies in these patients showed that the first case was due to a novel de novo heterozygous variant, c.377T>G (NM_000526.5 (c.377T>G, p.Leu126Arg)) in the KRT14 gene and the second case was due to a rare de novo heterozygous variant c.527A>G (NM_000424.4, c.527A>G, p.Asn176Ser) in the KRT5 gene. To our knowledge, the c.377T>G variant in the KRT14 gene has not been previously reported, and the c.527A>G variant in the KRT5 gene is a rare cause of severe generalized EBS. In severe generalized EBS, infants exhibit severe symptoms at the onset; however, they tend to improve with time. A precise genetic diagnosis in these two cases aided in counseling the families concerning the prognosis in their affected children and the recurrence risk for future pregnancies.
- 17 April 2020
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2020, 1-5
Open AccessSevere Generalized Epidermolysis Bullosa Simplex in Two Hong Kong Children due to De Novo Variants in KRT14 and KRT5
We report two Hong Kong children with severe generalized epidermolysis bullosa simplex (EBS), the most severe form of EBS, without a family history of EBS. EBS is a rare genodermatosis usually inherited in an autosomal dominant fashion although rare autosomal recessive cases have been reported. Genetic studies in these patients showed that the first case was due to a novel de novo heterozygous variant, c.377T>G (NM_000526.5 (c.377T>G, p.Leu126Arg)) in the KRT14 gene and the second case was due to a rare de novo heterozygous variant c.527A>G (NM_000424.4, c.527A>G, p.Asn176Ser) in the KRT5 gene. To our knowledge, the c.377T>G variant in the KRT14 gene has not been previously reported, and the c.527A>G variant in the KRT5 gene is a rare cause of severe generalized EBS. In severe generalized EBS, infants exhibit severe symptoms at the onset; however, they tend to improve with time. A precise genetic diagnosis in these two cases aided in counseling the families concerning the prognosis in their affected children and the recurrence risk for future pregnancies.